Galapagos NV (AMS: GLPG)
Netherlands
· Delayed Price · Currency is EUR 25.86
-0.44 (-1.67%)
Sep 4, 2024, 5:35 PM CET
Galapagos NV Employees
Galapagos NV had 1,123 employees as of December 31, 2023. The number of employees decreased by 215 or -16.07% compared to the previous year.
Employees
1,123
Change (1Y)
-215
Growth (1Y)
-16.07%
Revenue / Employee
€382,726
Profits / Employee
€413,754
Market Cap
1.73B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| ASML Holding N.V. | 40,309 |
| Prosus N.V. | 21,048 |
| Adyen N.V. | 4,196 |
| Heineken Holding N.V. | 89,732 |
| BE Semiconductor Industries N.V. | 1,736 |
| Holland Colours N.V. | 410 |
| Alumexx N.V. | 65 |
Galapagos NV News
- 23 hours ago - Galapagos receives transparency notification from FMR LLC - GlobeNewsWire
- 9 days ago - Galapagos up 10% as major shareholder intends to talk about strategy - Seeking Alpha
- 9 days ago - Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities' - Benzinga
- 9 days ago - Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats - Investor's Business Daily
- 9 days ago - Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday - Benzinga
- 11 days ago - Galapagos: CAR-T Biotech To Change Landscape With GLPG5101 And Beyond - Seeking Alpha
- 12 days ago - Galapagos gains after FDA nod for lymphoma trial - Seeking Alpha
- 12 days ago - Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma - GlobeNewsWire